Education
About Us
Working with TipRanks
Follow Us
Neuronetics Inc (STIM)
NASDAQ:STIM
STIM Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.52 - $5.92
Previous CloseN/A
Volume92.55K
Average Volume (3M)1.08M
Market Cap
$300.49M
Enterprise Value$298.34M
Total Cash (Recent Filing)$17.47M
Total Debt (Recent Filing)$25.12M
Price to Earnings (P/E)―
Beta1.56
Next Earnings
Nov 11, 2025EPS Estimate
-0.13Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.15
Shares Outstanding66,113,820
10 Day Avg. Volume1,089,649
30 Day Avg. Volume1,077,504
Financial Highlights & Ratios
PEG Ratio-0.04
Price to Book (P/B)1.84
Price to Sales (P/S)0.68
P/FCF Ratio-1.57
Enterprise Value/Market Cap0.99
Enterprise Value/Revenue2.69
Enterprise Value/Gross Profit4.78
Enterprise Value/Ebitda-7.55
Forecast
1Y Price Target
$7.00Price Target Upside75.00% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
Bulls Say, Bears Say
Bulls Say
AcquisitionThe acquisition is already showing benefits, with STIM expecting to reach cash flow positivity in Q3, with 90% of the anticipated deal synergies realized by year-end.
EarningsSTIM reported a solid Q1 operationally, with revenue of $32.0M, well above consensus estimates.
GuidanceManagement updated its FY25 guidance, raising the low-end of its revenue range, indicating confidence in future growth.
Bears Say
Cash FlowThe stock traded off on the higher-than-expected cash burn for Q1.
MarginGross margin decreased to 66.2% from 77.6% due to the inclusion of the lower margin Greenbrook operations.
Market PerformanceThe rating remains Market Perform until better visibility on the progress of the commercial strategy drivers and business model shift is gained.
Neuronetics News
STIM FAQ
What was Neuronetics Inc’s price range in the past 12 months?
Neuronetics Inc lowest stock price was $0.52 and its highest was $5.92 in the past 12 months.
What is Neuronetics Inc’s market cap?
Neuronetics Inc’s market cap is $300.49M.
When is Neuronetics Inc’s upcoming earnings report date?
Neuronetics Inc’s upcoming earnings report date is Nov 11, 2025 which is in 94 days.
How were Neuronetics Inc’s earnings last quarter?
Neuronetics Inc released its earnings results on Aug 05, 2025. The company reported -$0.15 earnings per share for the quarter, missing the consensus estimate of -$0.078 by -$0.072.
Is Neuronetics Inc overvalued?
According to Wall Street analysts Neuronetics Inc’s price is currently Undervalued.
Does Neuronetics Inc pay dividends?
Neuronetics Inc does not currently pay dividends.
What is Neuronetics Inc’s EPS estimate?
Neuronetics Inc’s EPS estimate is -0.13.
How many shares outstanding does Neuronetics Inc have?
Neuronetics Inc has 66,113,820 shares outstanding.
What happened to Neuronetics Inc’s price movement after its last earnings report?
Neuronetics Inc reported an EPS of -$0.15 in its last earnings report, missing expectations of -$0.078. Following the earnings report the stock price went down -2.575%.
Which hedge fund is a major shareholder of Neuronetics Inc?
Currently, no hedge funds are holding shares in STIM
Neuronetics Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$7.00 (75.00% Upside)
$7.00 (75.00% Upside)
Blogger Sentiment
Bullish
STIM Sentiment 100%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Increased
By 521.0K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $853.3K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 0.4%
Last 30 Days ▼ 5.2%
Last 30 Days ▼ 5.2%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
135.83%
12-Months-Change
Fundamentals
Return on Equity
-207.57%
Trailing 12-Months
Asset Growth
39.08%
Trailing 12-Months
Company Description
Neuronetics Inc
Neuronetics, Inc. (STIM) is a medical technology company focused on developing and commercializing products that improve the quality of life for patients suffering from psychiatric and neurological disorders. The company is best known for its NeuroStar Advanced Therapy System, a non-invasive, non-systemic, FDA-cleared transcranial magnetic stimulation (TMS) device designed to treat major depressive disorder (MDD) in adults who have not seen satisfactory improvement from prior antidepressant medication. Neuronetics operates within the healthcare sector, specifically targeting the medical device and mental health treatment markets.
STIM Company Deck
STIM Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call highlighted strong revenue growth, particularly in the Greenbrook clinics, and significant progress towards cash flow positivity. However, challenges such as a decline in gross margin, increased operating expenses, and ongoing difficulties with the SPRAVATO buy and bill model were also noted.View all STIM earnings summariesSTIM Stock 12 Month Forecast
Average Price Target
$7.00
▲(75.00% Upside)
Technical Analysis
Ownership Overview
9.54% Insiders
4.33% Mutual Funds
0.12% Other Institutional Investors
79.40% Public Companies and
Individual Investors